The aesthetic injectable market in Argentina is expected to reach a projected revenue of US$ 123.4 million by 2033. A compound annual growth rate of 9.3% is expected of Argentina aesthetic injectable market from 2026 to 2033.
Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc
Other key industry trends
In terms of revenue, Argentina accounted for 0.5% of the global aesthetic injectable market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Latin America, Brazil aesthetic injectable market is projected to lead the regional market in terms of revenue in 2033.
Argentina is the fastest growing regional market in Latin America and is projected to reach USD 123.4 million by 2033.
Argentina is a key country in the aesthetic injectable market. According to ISAPS, in 2022, 493,729 injectable procedures were performed in Argentina, of which 260,206 botulinum toxin procedures and nearly 227,321 HA-based procedures were performed.
Moreover, the country is showcasing readiness toward the adoption of advanced technologies & new global trends, and the geriatric population in the country is growing. The combination of a strong surgical workforce and a remarkable presence of healthcare facilities positions Argentina as a key player in fostering advancements and uptake of cosmetic procedures.
According to the ISAPS 2022, the availability of a substantial number of surgeons in Argentina, totaling 2,200, plays a pivotal role in driving growth. However, the country faces significant economic challenges.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Aesthetic Injectable Market will help companies and investors design strategic landscapes.
Botulinum Toxin (Botox) was the largest segment with a revenue share of 48.42% in 2025.
Horizon Databook has segmented the Argentina aesthetic injectable market based on collagen and pmma microspheres, hyaluronic acid, calcium hydroxylapatite (caha), plla, pcl, pn/pdrn, botulinum toxin (botox) covering the revenue growth of each sub-segment from 2021 to 2033.
Argentina is a key country in the aesthetic injectable market. According to ISAPS, in 2022, 493,729 injectable procedures were performed in Argentina, of which 260,206 botulinum toxin procedures and nearly 227,321 HA-based procedures were performed.
Moreover, the country is showcasing readiness toward the adoption of advanced technologies & new global trends, and the geriatric population in the country is growing. The combination of a strong surgical workforce and a remarkable presence of healthcare facilities positions Argentina as a key player in fostering advancements and uptake of cosmetic procedures.
According to the ISAPS 2022, the availability of a substantial number of surgeons in Argentina, totaling 2,200, plays a pivotal role in driving growth. However, the country faces significant economic challenges.
Argentina Aesthetic Injectable Market Product Outlook (Revenue, USD Million , 2021-2033)
Collagen and PMMA Microspheres
Hyaluronic Acid
Calcium Hydroxylapatite (CaHA)
PLLA
PCL
PN/PDRN
Botulinum Toxin (Botox)
Argentina Aesthetic Injectable Market Application Outlook (Revenue, USD Million , 2021-2033)
Wrinkle Correction
Lip Augmentation
Facial Contouring
Scar Treatment
Volume Loss Restoration
Others
Argentina Aesthetic Injectable Market End Use Outlook (Revenue, USD Million , 2021-2033)
MedSpas
Aesthetic Surgery Centers
Hospitals
Others
Reasons to subscribe to Aesthetic Injectable Market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Aesthetic Injectable Market databook
Our clientele includes a mix of Aesthetic Injectable Market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina Aesthetic Injectable Market, including forecasts for subscribers. This country databook contains high-level insights into Argentina Aesthetic Injectable Market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Argentina Aesthetic Injectable Market, 2021-2033 (US$M)